Health
Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects – News-Medical.Net
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways…
Reviewed by Emily Henderson, B.Sc.Nov 23 2020
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
The study results, published today in Nature Metabolism, provide proof…
-
General11 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News16 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General22 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
General12 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery